Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Zipp

Showing results (41-50 of 317) with videos related to

Pageof 32
Sort By:
Nature Reviews. Neurology|July 10, 2023
Implications of immunometabolism for smouldering MS pathology and therapyStefan Bittner, Katrin Pape, Luisa Klotz, et al.
Pharmacology & Therapeutics|January 19, 2023
Interleukin-4 as a therapeutic targetYvonne Gärtner, Lynn Bitar, Frauke Zipp, et al.
Nature Reviews. Neurology|May 16, 2019
Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosisFrauke Zipp, Jiwon Oh, Yara Dadalti Fragoso, et al.
Advances in Immunology|November 6, 2007
New insights into adaptive immunity in chronic neuroinflammationVolker Siffrin, Alexander U Brandt, Josephine Herz, et al.
Journal of the Neurological Sciences|December 16, 2006
Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancyStefan Ehrlich, Judith Haas, Frauke Zipp, et al.
Cytokine & Growth Factor Reviews|August 26, 2014
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developmentsDirk W Luchtman, Erik Ellwardt, Catherine Larochelle, et al.
Cytokine|November 12, 2003
Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytesStefan Ehrlich, Carmen Infante-Duarte, Bibiane Seeger, et al.
Trends in Immunology|January 19, 2016
Understanding the Role of T Cells in CNS HomeostasisErik Ellwardt, James T Walsh, Jonathan Kipnis, et al.
Journal of Neuroimmunology|January 5, 2002
Induction of TRAIL-mediated glioma cell death by human T cellsJan Dörr, Sonia Waiczies, Uwe Wendling, et al.
Trends in Neurosciences|March 13, 2013
Neurons as targets for T cells in the nervous systemRoland S Liblau, Daniel Gonzalez-Dunia, Heinz Wiendl, et al.
Pageof 32

Showing results (41-50 of 317) with videos related to

Sort By:
Pageof 32
Nature Reviews. Neurology|July 10, 2023
Implications of immunometabolism for smouldering MS pathology and therapyStefan Bittner, Katrin Pape, Luisa Klotz, et al.
Pharmacology & Therapeutics|January 19, 2023
Interleukin-4 as a therapeutic targetYvonne Gärtner, Lynn Bitar, Frauke Zipp, et al.
Nature Reviews. Neurology|May 16, 2019
Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosisFrauke Zipp, Jiwon Oh, Yara Dadalti Fragoso, et al.
Advances in Immunology|November 6, 2007
New insights into adaptive immunity in chronic neuroinflammationVolker Siffrin, Alexander U Brandt, Josephine Herz, et al.
Journal of the Neurological Sciences|December 16, 2006
Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancyStefan Ehrlich, Judith Haas, Frauke Zipp, et al.
Cytokine & Growth Factor Reviews|August 26, 2014
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developmentsDirk W Luchtman, Erik Ellwardt, Catherine Larochelle, et al.
Cytokine|November 12, 2003
Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytesStefan Ehrlich, Carmen Infante-Duarte, Bibiane Seeger, et al.
Trends in Immunology|January 19, 2016
Understanding the Role of T Cells in CNS HomeostasisErik Ellwardt, James T Walsh, Jonathan Kipnis, et al.
Journal of Neuroimmunology|January 5, 2002
Induction of TRAIL-mediated glioma cell death by human T cellsJan Dörr, Sonia Waiczies, Uwe Wendling, et al.
Trends in Neurosciences|March 13, 2013
Neurons as targets for T cells in the nervous systemRoland S Liblau, Daniel Gonzalez-Dunia, Heinz Wiendl, et al.
Pageof 32